Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

A supplement to Clinical Neurology News. This supplement was supported by Talecris Biotherapeutics.

• Diagnosing CIDP

• Therapeutic Options

• The ICE Study

• Best Practices: Key Takeaways

Faculty/Faculty Disclosures

Vera Bril, MD
Department of Neurology
University Health Network
Toronto, Ontario, Canada
Dr. Bril was a consultant with Talecris Biotherapeutics.

Copyright © 2008 Elsevier Inc.

To view the supplement, click the image above.

A supplement to Clinical Neurology News. This supplement was supported by Talecris Biotherapeutics.

• Diagnosing CIDP

• Therapeutic Options

• The ICE Study

• Best Practices: Key Takeaways

Faculty/Faculty Disclosures

Vera Bril, MD
Department of Neurology
University Health Network
Toronto, Ontario, Canada
Dr. Bril was a consultant with Talecris Biotherapeutics.

Copyright © 2008 Elsevier Inc.

To view the supplement, click the image above.

A supplement to Clinical Neurology News. This supplement was supported by Talecris Biotherapeutics.

• Diagnosing CIDP

• Therapeutic Options

• The ICE Study

• Best Practices: Key Takeaways

Faculty/Faculty Disclosures

Vera Bril, MD
Department of Neurology
University Health Network
Toronto, Ontario, Canada
Dr. Bril was a consultant with Talecris Biotherapeutics.

Copyright © 2008 Elsevier Inc.

To view the supplement, click the image above.